Annual Total Liabilities
$546.23 M
+$137.90 M+33.77%
December 31, 2023
Summary
- As of February 7, 2025, GMAB annual total liabilities is $546.23 million, with the most recent change of +$137.90 million (+33.77%) on December 31, 2023.
- During the last 3 years, GMAB annual total liabilities has risen by +$212.02 million (+63.44%).
- GMAB annual total liabilities is now at all-time high.
Performance
GMAB Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$1.16 B
+$60.84 M+5.54%
September 1, 2024
Summary
- As of February 7, 2025, GMAB quarterly total liabilities is $1.16 billion, with the most recent change of +$60.84 million (+5.54%) on September 1, 2024.
- Over the past year, GMAB quarterly total liabilities has increased by +$574.65 million (+98.34%).
- GMAB quarterly total liabilities is now at all-time high.
Performance
GMAB Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
GMAB Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +33.8% | +98.3% |
| 3 y3 years | +63.4% | +147.1% |
| 5 y5 years | +697.7% | +147.1% |
GMAB Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +47.6% | at high | +251.9% |
| 5 y | 5-year | at high | +232.4% | at high | +767.2% |
| alltime | all time | at high | +3347.7% | at high | +2565.6% |
Genmab A/S Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.16 B(+5.5%) |
| Jun 2024 | - | $1.10 B(+81.5%) |
| Mar 2024 | - | $605.09 M(+10.8%) |
| Dec 2023 | $546.23 M(+33.8%) | $546.23 M(-6.5%) |
| Sep 2023 | - | $584.36 M(+24.2%) |
| Jun 2023 | - | $470.33 M(+0.3%) |
| Mar 2023 | - | $469.01 M(+14.9%) |
| Dec 2022 | $408.32 M(+10.3%) | $408.32 M(-23.3%) |
| Sep 2022 | - | $532.52 M(+26.7%) |
| Jun 2022 | - | $420.35 M(+27.6%) |
| Mar 2022 | - | $329.39 M(-11.0%) |
| Dec 2021 | $370.09 M(+10.7%) | $370.09 M(-12.1%) |
| Sep 2021 | - | $421.23 M(+18.0%) |
| Jun 2021 | - | $357.03 M(+7.1%) |
| Mar 2021 | - | $333.36 M(-0.3%) |
| Dec 2020 | $334.21 M(+103.4%) | $334.21 M(-30.4%) |
| Sep 2020 | - | $480.12 M(+13.2%) |
| Jun 2020 | - | $424.20 M(+217.4%) |
| Mar 2020 | - | $133.66 M(-18.7%) |
| Dec 2019 | $164.31 M(+140.0%) | $164.31 M(+37.5%) |
| Sep 2019 | - | $119.53 M(+13.6%) |
| Jun 2019 | - | $105.24 M(+15.3%) |
| Mar 2019 | - | $91.30 M(+33.3%) |
| Dec 2018 | $68.48 M(+28.5%) | $68.48 M(+35.6%) |
| Sep 2018 | - | $50.50 M(-3.8%) |
| Jun 2018 | - | $52.50 M(+20.7%) |
| Mar 2018 | - | $43.48 M(-18.4%) |
| Dec 2017 | $53.30 M(-8.9%) | $53.30 M(-21.4%) |
| Sep 2017 | - | $67.80 M(-25.2%) |
| Jun 2017 | - | $90.63 M(+58.0%) |
| Mar 2017 | - | $57.37 M(-2.0%) |
| Dec 2016 | $58.53 M | $58.53 M(-7.2%) |
| Sep 2016 | - | $63.05 M(+11.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2016 | - | $56.77 M(-4.2%) |
| Mar 2016 | - | $59.28 M(-2.7%) |
| Dec 2015 | $60.91 M(-55.3%) | $60.91 M(-12.6%) |
| Sep 2015 | - | $69.68 M(-9.8%) |
| Jun 2015 | - | $77.29 M(-9.2%) |
| Mar 2015 | - | $85.11 M(-37.5%) |
| Dec 2014 | $136.13 M(-31.4%) | $136.13 M(-11.0%) |
| Sep 2014 | - | $152.96 M(-13.6%) |
| Jun 2014 | - | $177.00 M(-6.4%) |
| Mar 2014 | - | $189.17 M(-4.7%) |
| Dec 2013 | $198.42 M(-14.5%) | $198.42 M(-14.6%) |
| Sep 2013 | - | $232.25 M(+12.7%) |
| Jun 2013 | - | $206.16 M(-5.3%) |
| Mar 2013 | - | $217.68 M(-6.2%) |
| Dec 2012 | $232.13 M(+23.6%) | $232.13 M(-4.5%) |
| Sep 2012 | - | $243.06 M(+44.8%) |
| Jun 2012 | - | $167.86 M(-9.1%) |
| Mar 2012 | - | $184.76 M(-1.6%) |
| Dec 2011 | $187.85 M(-24.9%) | $187.85 M(-9.6%) |
| Sep 2011 | - | $207.72 M(-8.7%) |
| Jun 2011 | - | $227.50 M(-3.4%) |
| Mar 2011 | - | $235.53 M(-5.8%) |
| Dec 2010 | $250.02 M(+40.6%) | $250.02 M(+4.3%) |
| Sep 2010 | - | $239.78 M(+94.6%) |
| Jun 2010 | - | $123.22 M(-21.7%) |
| Mar 2010 | - | $157.35 M(-11.5%) |
| Dec 2009 | $177.79 M(-11.5%) | $177.79 M |
| Dec 2008 | $200.87 M(-4.5%) | - |
| Dec 2007 | $210.33 M(+503.5%) | - |
| Dec 2006 | $34.85 M(-12.7%) | - |
| Dec 2005 | $39.92 M(+141.2%) | - |
| Dec 2004 | $16.55 M(+4.5%) | - |
| Dec 2003 | $15.84 M(-39.0%) | - |
| Dec 2002 | $25.97 M | - |
FAQ
- What is Genmab A/S annual total liabilities?
- What is the all time high annual total liabilities for Genmab A/S?
- What is Genmab A/S annual total liabilities year-on-year change?
- What is Genmab A/S quarterly total liabilities?
- What is the all time high quarterly total liabilities for Genmab A/S?
- What is Genmab A/S quarterly total liabilities year-on-year change?
What is Genmab A/S annual total liabilities?
The current annual total liabilities of GMAB is $546.23 M
What is the all time high annual total liabilities for Genmab A/S?
Genmab A/S all-time high annual total liabilities is $546.23 M
What is Genmab A/S annual total liabilities year-on-year change?
Over the past year, GMAB annual total liabilities has changed by +$137.90 M (+33.77%)
What is Genmab A/S quarterly total liabilities?
The current quarterly total liabilities of GMAB is $1.16 B
What is the all time high quarterly total liabilities for Genmab A/S?
Genmab A/S all-time high quarterly total liabilities is $1.16 B
What is Genmab A/S quarterly total liabilities year-on-year change?
Over the past year, GMAB quarterly total liabilities has changed by +$574.65 M (+98.34%)